Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer November 2021 22(6):587-595 - Subject
- Language
- ISSN
- 1525-7304